Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Recent data demonstrated that activation of the muscarinic M 1 receptor by a subtype-selective positive allosteric modulator (PAM) contributes to the gastrointestinal (GI) and cardiovascular (CV) cholinergic adverse events (AEs) previously attributed to M 2 and M 3 activation. These studies were conducted using PAMs that also exhibited allosteric agonist activity, leaving open the possibility that direct activation by allosteric agonism, rather than allosteric modulation, could be responsible for the adverse effects. This article describes the design and synthesis of lactam-derived M 1 PAMs that address this hypothesis. The lead molecule from this series, compound 1 (PF-06827443), is a potent, low-clearance, orally bioavailable, and CNS-penetrant M 1 -selective PAM with minimal agonist activity. Compound 1 was tested in dose escalation studies in rats and dogs and was found to induce cholinergic AEs and convulsion at therapeutic indices similar to previous compounds with more agonist activity. These findings provide preliminary evidence that positive allosteric modulation of M 1 is sufficient to elicit cholinergic AEs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity
Seol, G. H., Ziburkus, J., Huang, S., Song, L., Kim, I. T., Takamiya, K., Huganir, R. L., Lee, H.-K., & Kirkwood, A. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.013 · Cited by 429
Research works printed but not linked: 59
- 10.1007/s12031-002-0031-5 · DOI
- 10.1176/appi.ajp.2008.08050769 · DOI
- 10.1001/archneur.1997.00550160091022 · DOI · Paper page
- 10.1176/appi.ajp.2008.06091591 · DOI · Paper page
- 10.1016/j.neuron.2010.11.018 · DOI · Paper page
- 10.1523/JNEUROSCI.2338-05.2005 · DOI · Paper page
- 10.1038/nn992 · DOI · Paper page
- 10.2147/NDT.S55104 · DOI · Paper page
- 10.1016/j.eururo.2007.12.007 · DOI
- 10.1016/j.archoralbio.2007.07.012 · DOI
- 10.1038/nature12735 · DOI · Paper page
- 10.1038/ng.2653 · DOI · Paper page
- 10.1073/pnas.0900903106 · DOI · Paper page
- 10.1021/jm200400m · DOI
- 10.1007/s00213-012-2788-8 · DOI
- 10.1124/jpet.115.226712 · DOI
- 10.2174/1568026614666140826120224 · DOI
- 10.1021/ml300280g · DOI
- 10.1016/j.bmcl.2014.01.012 · DOI
- 10.1021/ml100095k · DOI
- 10.1016/j.bmcl.2010.01.013 · DOI
- 10.1016/j.bmcl.2011.01.094 · DOI
- 10.1016/j.bmcl.2010.10.028 · DOI
- 10.1021/ml500055h · DOI
- 10.1016/j.bmcl.2015.11.053 · DOI
- 10.1021/acs.jmedchem.6b00544 · DOI · Paper page
- 10.1021/acschemneuro.6b00429 · DOI
- 10.1016/j.bmcl.2010.01.109 · DOI
- 10.1016/j.bmcl.2014.11.011 · doi:10.1016/j.bmcl.2014.11.011
- 10.1016/j.bmcl.2012.11.092 · DOI
- 10.1016/j.bmcl.2016.04.083 · DOI
- 10.1016/j.bmcl.2013.01.017 · DOI
- 10.1016/j.bmcl.2010.12.015 · DOI
- 10.1021/acschemneuro.6b00018 · DOI
- 10.1021/jm400540b · DOI · Paper page
- 10.1021/acs.jmedchem.5b01562 · DOI
- 10.1016/0006-8993(94)90017-5 · DOI
- 10.1073/pnas.94.24.13311 · DOI · Paper page
- 10.1046/j.1460-9568.2003.02588.x · DOI · Paper page
- 10.1124/jpet.115.226910 · DOI
- 10.1002/anie.200902262 · doi:10.1002/anie.200902262
- 10.1016/j.bmcl.2009.05.062 · DOI · Paper page
- 10.1021/jm0100990 · DOI · Paper page
- 10.1111/j.1753-5174.2010.00032.x · DOI
- 10.1152/jn.00686.2010 · DOI · Paper page
- 10.1038/bjp.2008.152 · DOI · Paper page
- 10.2174/156802609789753635 · doi:10.2174/156802609789753635
- 10.1111/j.1748-1716.1978.tb06302.x · DOI
- Luttrell L. M., 2002, J. Cell Sci., 115, 455, 10.1242/jcs.115.3.455 · DOI · Paper page
- 10.1098/rspb.1983.0093 · DOI · Paper page
- 10.1021/acs.biochem.6b00688 · DOI
- 10.1037/0735-7044.100.4.476 · doi:10.1037/0735-7044.100.4.476 · Paper page
- 10.1016/0165-0270(84)90007-4 · DOI · Paper page
- Patel V. R., 2011, J. Adv. Pharm. Technol. Res., 2, 81, 10.4103/2231-4040.79799 · DOI
- 10.1021/mp8000793 · DOI · Paper page
- 10.1016/j.jneumeth.2008.04.019 · DOI · Paper page
- 10.1038/nrd3649 · DOI · Paper page
- 10.3389/fnbeh.2014.00252 · DOI · Paper page
- 10.1124/mol.116.104737 · doi:10.1124/mol.116.104737
Cited by
Reimagining cholinergic therapy for Alzheimer’s disease
Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias
van der Westhuizen, E. T., Choy, K. H. C., Valant, C., McKenzie-Nickson, S., Bradley, S. J., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606656 · Cited by 63
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Dwomoh, L., Tejeda, G. S., & Tobin, A. B. (2022) · Neuronal Signaling · doi:10.1042/ns20210004 · Cited by 60
Metadata
- Authors
- Davoren, J. E., Garnsey, M., Pettersen, B., Brodney, M. A., Edgerton, J. R., Fortin, J.-P., Grimwood, S., Harris, A. R., Jenkinson, S., Kenakin, T., Lazzaro, J. T., Lee, C.-W., Lotarski, S. M., Nottebaum, L., O’Neil, S. V., Popiolek, M., Ramsey, S., Steyn, S. J., Thorn, C. A., Zhang, L., & Webb, D.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-07-26
- Volume
- 60
- Issue
- 15
- Pages
- 6649-6663
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2622234382
- Cited by
- 60
- References
- 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. https://app.cochat.ai/papers/10.1021/acs.jmedchem.7b00597
- The paper
- Davoren, J. E., Garnsey, M., Pettersen, B., Brodney, M. A., Edgerton, J. R., Fortin, J.-P., Grimwood, S., Harris, A. R., Jenkinson, S., Kenakin, T., Lazzaro, J. T., Lee, C.-W., Lotarski, S. M., Nottebaum, L., O’Neil, S. V., Popiolek, M., Ramsey, S., Steyn, S. J., Thorn, C. A., . . . Webb, D. (2017). Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00597
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.